Status:
UNKNOWN
Feasibility and Effect of a Follow up Tele-rehabilitation Program for Chronic Obstructive Lung Disease vs. Standard Follow up
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Eurostars
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Introduction In order to guarantee chronic patients \& elderly a high quality service from health care organizations in the coming decades, new technologies have been implemented to treat patients fro...
Detailed Description
Intro To guarantee chronic patients and elderly a high quality service from health care organizations in the coming decades, new technologies has been implemented to treat patients from a distance. T...
Eligibility Criteria
Inclusion
- Stable COPD
- Signed informed consent
- Completion of the standard rehabilitation program
- Permanent oxygen therapy is not an obstacle for participation.
Exclusion
- The patient has significant musculoskeletal disorders that limit his / her function levels to a degree that is not caused by dyspnea
- The patient has pronounced dizziness, significant sensory or motor disability, dementia or terminal malignant disease
- Serious comorbidities (unstable heart disease, irregular diabetes, known malignant disease, another disease that makes the patient unfit to participate in the study).
- Non-compliant patient (eg. Nursing Homes Residents)
- Participation in another project within the last 30 days
- Mini-Mental State Examination score less than 24 points
- Severe vision or hearing loss.
- Non-Danish speaking.
- Lack of will to implement the protocol.
- Motor or sensory disease, which makes it impossible for walk training
- Have experienced a worsening in the last 4-6 weeks
- Musculoskeletal disorders
- Serious heart diseases (ejection fraction \<30%, daily angina, or as indicated by treating the cardiologist)
- Can not understand informed consent
- Other factors that inhibit the use of telerehabilitation
Key Trial Info
Start Date :
March 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 30 2021
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT03443817
Start Date
March 1 2018
End Date
January 30 2021
Last Update
February 28 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Jose Cerdan
Aarhus, Danmark, Denmark, 8000